Intravascular Stents Market to Grow with a CAGR of 7.30% through 2029

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Intravascular Stents Market growth in the forecast period, 2025-2029.

 

According to TechSci Research report, “Intravascular Stents Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2029F”, the Global Intravascular Stents Market was valued at USD 11.98 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 7.30% through 2029. The growth in the demand for intravascular stents can be attributed to collaborations and partnerships among leading companies, combining their expertise to strengthen market positions. A significant driver is the preference for minimally invasive procedures over traditional open surgeries due to their shorter hospital stays, quicker recovery times, and reduced post-operative pain and scarring. These procedures offer a less disruptive experience for patients and result in lower healthcare costs due to reduced hospitalization and resource use. The improved safety profile, with fewer complications like infections, makes these procedures especially appealing for high-risk patients. Patients can return to normal activities more quickly, enhancing their overall experience and satisfaction. Minimally invasive techniques are valuable for high-risk patients, such as those with multiple comorbidities or older adults. Advances in imaging technology, like fluoroscopy and intravascular ultrasound, enhance the precision and safety of stent placement. Additionally, these procedures typically involve minimal blood loss, crucial for patients with coagulation disorders or anemia.

However, biocompatibility and long-term safety remain significant challenges in the global intravascular stents market, as they directly impact patient outcomes and the success of stent interventions. Stents, especially drug-eluting stents (DES), can provoke inflammatory responses in blood vessels due to foreign materials, leading to complications such as restenosis and stent thrombosis. Biocompatibility issues can contribute to late stent thrombosis, a potentially life-threatening complication associated with incomplete endothelialization and proinflammatory responses. Allergic reactions to materials like nickel or polymers used in stent construction can also pose risks. The biocompatibility of drug-eluting stent coatings is a concern, as certain polymers and drug carriers can cause local inflammation and adverse tissue reactions. Achieving complete and healthy endothelialization of the stented area is essential for long-term safety to avoid complications like restenosis. Stent surfaces must minimize thrombogenicity to reduce the risk of clot-related complications. Additionally, stent migration or fracture over time can cause injuries or necessitate further intervention, highlighting the importance of durable, biocompatible stent materials.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global Intravascular Stents Market”

Global Intravascular Stents Market is segmented based on product, type, end-use, regional distribution, and company. 

Based on Type, Bare Metal Stents have emerged as the fastest growing segment in the Global Intravascular Stents Market in 2023. Bare metal stents are more cost-effective than drug-eluting stents, making them an attractive option for healthcare systems, especially in developing regions with budget constraints. BMS require a shorter duration of dual antiplatelet therapy compared to DES, benefiting patients at high risk of bleeding or those unable to adhere to prolonged DAPT regimens. In emerging markets, the affordability of bare metal stents increases their accessibility to a broader patient population. Additionally, the enhancement of healthcare infrastructure in these regions supports the wider adoption of BMS. Advances in materials and stent design have improved the performance and safety profile of bare metal stents, making them more competitive with drug-eluting stents.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Intravascular Stents Market in 2023. Economic expansion and rising personal incomes are fueling escalated healthcare expenditures within the region. This uptick in spending facilitates amplified investments in cutting-edge medical solutions, including intravascular stents. The surge in cardiovascular ailments, such as coronary artery disease, is attributable to shifting lifestyles, aging demographics, and genetic predispositions. This mounting prevalence of heart-related conditions propels the demand for efficacious remedies like intravascular stents. Furthermore, there is a heightened consciousness regarding cardiovascular well-being and the significance of prompt diagnosis and treatment. As a result, more individuals are opting for routine health assessments and cardiovascular screenings, leading to the early identification and management of heart ailments through intravascular stents.

Some of the major companies operating in the Global Intravascular Stents Market include:

• Boston Scientific Corporation              
• Medtronic plc.                   
• Terumo Medical Corporation       
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG 
• Stryker Corporation          
• Microport Scientific Corporation                  
• Stentys S.A.                   
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

 

Download Sample Report

Customers can also request 10% free customization on this report

“Specific regions, notably in North America, are anticipated to drive substantial demand for Intravascular Stents. The expansion of the market's competitive arena, coupled with the established presence of companies dedicated to improving people's overall health annually, is poised to fuel remarkable growth in the Global Intravascular Stents Market during the forecast period", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Intravascular Stents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), By Product (Coronary Stents, Peripheral Stents), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2019-2029F" has evaluated the future growth potential of Global Intravascular Stents Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Intravascular Stents Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com